Many Inflammatory Breast Cancer (IBC) patients who were diagnosed with this disease in 1997 or more recently, have contributed their inspiring stories to this website to provide encouragement to other victims of this deadly type of breast cancer.
We are committed to finding the cause of IBC and educating the medical community and the public about this deadly form of breast cancer. We have two websites with information and callers can be linked with a survivor to answer questions or provide information.
Many long-term survivors of Inflammatory Breast Cancer (IBC) have contributed their inspiring stories to this website to provide hope to other victims of this deadly type of breast cancer.
This Memorial Site honors hundreds of Inflammatory Breast Cancer (IBC) patients who were the victims of this deadly disease. Please read the beautiful tributes to them by their friends and relatives.
This site lists the unique symptoms of Inflammatory Breast Cancer (IBC) in English, French, German, Spanish, Hungarian, Vietnamese, Italian, and Portuguese.
Description of Inflammatory Breast Cancer, survivor stories, advocacy information, discussion list, and more.
Overview of different types of breast cancer, research information, treatment information with links to many other breast cancer resources including inflammatory breast cancer research foundation.
B.E.S.T. Friends meets the second and fourth Thursdays of each month from 7 - 8:30 pm., at the ACS office building. This is a peer lead support group and includes women at all stages of treatment for breast cancer. The newly diagnosed, the survivor and those with metastatic disease are all welcome. Meetings are informal and confidential. Educational programs are offered periodically. This group is independent and not affiliated with ACS or the local hospital.
Professor Plant (herself a breast cancer survivor) gives her anti-cancer diet plan ie removing all dairy products from you diet and eating mostly organic fruit and vegetables.
Information, support, campaign details and lots more.